Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

Ranbaxy eyes drug launches in US with marketing exclusivity

Jun 19, 2013 at 22:12 | Source: Financial Express

Drug major Ranbaxy Laboratories said on Thursday it plans to launch more generic products in the US market with possible marketing exclusivity while keeping options open for overseas acquisitions to grow its business in various global markets. �ï¿...

Ranbaxy to appeal against EU fine

Jun 19, 2013 at 21:10 | Source: Business Today

The European Commission on Wednesday imposed fines on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper generic versions of Danish company Lundbeck's drug Citalopram, an antidepressant. Ranbaxy has been fine...

Ranbaxy Laboratories, 8 others fined by EU for blocking cheaper drugs

Jun 19, 2013 at 20:01 | Source: Business Today

PHOTO: Associated Press The European Commission has imposed a fine of 146 million euros on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper generic versions of Danish company Lundbeck's branded citalopram, ...

Ranbaxy Laboratories, Lundbeck, others fined for blocking cheaper drugs

Jun 19, 2013 at 19:37 | Source: Financial Express

European Union antitrust regulators fined nine drugmakers, including Ranbaxy Laboratories, a total of 146 million euros on Wednesday for blocking the supply of cheaper medicines on the market, with a penalty of 94 million euros imposed on Denmark's ...

EU regulator fines Ranbaxy, 8 others over Citalopram generic delay

Jun 19, 2013 at 19:37 | Source: The Hindu BusinessLine

New Delhi, June 19: The European Commission today imposed a fine of €146 million on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper generic versions of Danish company Lundbeck’s branded citalop...

Markets recover slightly ahead of Fed outcome, Telecom stocks gain

Jun 19, 2013 at 15:59 | Source: FirstPost

The Indian markets recovered slightly today amid volatility ahead of the US Federal Reserve policy outcome.The BSE Sensex closed at 19240.32, up 0.09 percent while the Nifty closed at 5820.85, up 0.12 percent.Global financial markets are on the edge,...

Let's set a global drug quality benchmark

Jun 18, 2013 at 17:06 | Source: Business Today

PHOTO: Associated Press Kiran Mazumdar-ShawWith Indian-made generics accounting for a US market share of over 25 per cent, it is not surprising that it is gaining significant mindshare of the American drug regulator, the Food and Drug Administration...

Nifty ends near 5,800; Ranbaxy, PNB and NTPC down

Jun 18, 2013 at 16:31 | Source: Economic Times

MUMBAI: The Nifty extended intraday losses in the last hour of trade but closed above the psychological support of 5,800 ahead of the US Federal Reserve meeting. All the sectoral indices except IT and metals ended in the red with capital goods, banks...

SC to hear plea against Ranbaxy Laboratories on June 24

Jun 18, 2013 at 12:31 | Source: Business Today

PHOTO: Associated Press The Supreme Court will on June 24 hear a petition seeking probe against Ranbaxy Laboratories for allegedly manufacturing and selling adulterated medicines.A bench of justices A K Patnaik and Ranjan Gogoi have agreed to hear t...

Nifty rangebound; banks, auto and capital goods down

Jun 18, 2013 at 11:21 | Source: Economic Times

MUMBAI: The Nifty was witnessing a rangebound session with a negative bias in line with other global markets ahead of the US Federal Reserve meeting. Gains in realty and technology sectors were offset by losses in banks, auto and capital goods secto...

Apex court to hear plea against Ranbaxy on Jun 24

Jun 17, 2013 at 18:32 | Source: The Hindu BusinessLine

New Delhi, Jun 17: Supreme Court will hear on June 24 a petition seeking probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling adulterated medicines. A bench of justices A K Patnaik and Ranjan Gogoi today agreed to hear the ...

Supreme Court to hear plea against Ranbaxy on June 24

Jun 17, 2013 at 17:41 | Source: DNA India

Supreme Court will hear on June 24 a petition seeking probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling adulterated medicines. A bench of justices AK Patnaik and Ranjan Gogoi on Monday agreed to hear the PIL after the pe...

Supreme Court to hear plea against Ranbaxy Laboratories on June 24

Jun 17, 2013 at 17:36 | Source: Economic Times

NEW DELHI: Supreme Court will hear on June 24 a petition seeking probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling adulterated medicines. A bench of justices A K Patnaik and Ranjan Gogoi today agreed to hear the PIL afte...

BSE Sensex ends up 148 pts, Nifty rises to 5,850 even as RBI leaves rates unchanged

Jun 17, 2013 at 16:25 | Source: Economic Times

MUMBAI: The Nifty continued with its upwards momentum and closed near psychological resistance level of 5,850, after the Reserve Bank of India, in line with market expectations, maintained status quo on interest rates. "RBI kept the policy rates unc...

BSE Sensex down 45 points, Tata Motors, Jet Airways shares rise

Jun 16, 2013 at 21:17 | Source: Financial Express

BSE Sensex dropped by 45.14 points or 0.22% at 20,102.50 in early trade today. Shares of Tata Motors, Jet Airways, Ranbaxy Laboratories, and IOC were among the major gainers, while Wockhardt, HDIL, ICICI Bank and DLF were trading in red zone. Sensex...

Project revital

Jun 15, 2013 at 13:11 | Source: Business Today

India's pharmaceutical industry suffered twin blows recently when Ranbaxy Laboratories and Wockhardt, two of the country's biggest drug makers, came under fire from US authorities. While Ranbaxy on May 13 admitted to fudging data , Wockhardt said on...

Ranbaxy eyes U.S. drug launches with sales exclusivity

Jun 14, 2013 at 05:15 | Source: FirstPost

MUMBAI (Reuters) - Ranbaxy Laboratories (RANB.NS), India's No.1 drugmaker by sales, plans to file three to four generic drug applications every year that can earn it a six-month marketing exclusivity in the United States, the company's chief executiv...

Apollo Pharmacy to sell Ranbazy drugs, says issue resolved

Jun 13, 2013 at 22:17 | Source: FirstPost

New Delhi: A week after issuing cautionary advisory against drugs made by Ranbaxy Laboratories, leading pharmacy chain Apollo Pharmacy today said it has resolved the matter and will continue to sell the drug makers medicines from its outlets across t...

Ranbaxy issue resolved, says Apollo Pharmacy

Jun 13, 2013 at 20:37 | Source: The Hindu BusinessLine

New Delhi, June 13: A week after issuing “cautionary advisory” against drugs made by Ranbaxy Laboratories, leading pharmacy chain Apollo Pharmacy today said it has resolved the matter and will continue to sell the drug maker’s medi...

Ranbaxy to launch more drugs in US; eyes global acquisitions

Jun 13, 2013 at 20:37 | Source: The Hindu BusinessLine

Gurgaon, June 13: Drug major Ranbaxy Laboratories today said it plans to launch more generic products in the US market with possible marketing exclusivity, while keeping options open for overseas acquisitions to grow its business in various global m...

Best online resources for GMAT
As it happened: Death toll in U'khand at 150, likely to rise "As it happened: Death toll in U'khand at 150, likely to rise"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

Jun 19 2013, 23:15

Buy quality NBFCs with a shot at setting up a bank: Motilal

- in MARKET OUTLOOK

Jun 19 2013, 12:44

Weak rupee to benefit export oriented IT cos: Dipan Mehta

- in MARKET OUTLOOK

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window